Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Cycle Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis Patients
NCT06938152Phase 4Recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- Apr 2025
- Primary completion
- Apr 2029
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of romosozumab, denosumab in osteoporosis, sponsored by National Taiwan University Hospital. Started Apr 2025; status: recruiting.
02
Drugs
romosozumabdenosumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT06938152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06938152.